Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Modeling cellular response in large-scale radiogenomic databases to advance precision radiotherapy.

Manem VS, Lambie M, Smith I, Smirnov P, Kofia V, Freeman M, Koritzinsky M, Abazeed ME, Haibe-Kains B, Bratman SV.

Cancer Res. 2019 Sep 26. pii: canres.0179.2019. doi: 10.1158/0008-5472.CAN-19-0179. [Epub ahead of print]

PMID:
31558563
2.

Creating reproducible pharmacogenomic analysis pipelines.

Mammoliti A, Smirnov P, Safikhani Z, Ba-Alawi W, Haibe-Kains B.

Sci Data. 2019 Sep 3;6(1):166. doi: 10.1038/s41597-019-0174-7.

3.

Integrative Pharmacogenomics Analysis of Patient-Derived Xenografts.

Mer AS, Ba-Alawi W, Smirnov P, Wang YX, Brew B, Ortmann J, Tsao MS, Cescon DW, Goldenberg A, Haibe-Kains B.

Cancer Res. 2019 Sep 1;79(17):4539-4550. doi: 10.1158/0008-5472.CAN-19-0349. Epub 2019 May 29.

PMID:
31142512
4.

Dr.VAE: improving drug response prediction via modeling of drug perturbation effects.

Rampášek L, Hidru D, Smirnov P, Haibe-Kains B, Goldenberg A.

Bioinformatics. 2019 Oct 1;35(19):3743-3751. doi: 10.1093/bioinformatics/btz158.

5.

Temporal enhancement of 2D color Doppler echocardiography sequences by fragment-based frame reordering and refinement.

Terentjev AB, Perrin DP, Settlemier SH, Zurakowski D, Smirnov PO, Del Nido PJ, Shturts IV, Vasilyev NV.

Int J Comput Assist Radiol Surg. 2019 Apr;14(4):577-586. doi: 10.1007/s11548-019-01926-0. Epub 2019 Feb 23.

PMID:
30798510
6.

Ultrastructure and functional morphology of dermal glands in the freshwater mite Limnochares aquatica (L., 1758) (Acariformes, Limnocharidae).

Shatrov AB, Soldatenko EV, Stolbov VA, Smirnov PA, Petukhova OA.

Arthropod Struct Dev. 2019 Mar;49:85-102. doi: 10.1016/j.asd.2018.11.010. Epub 2018 Dec 19.

PMID:
30496890
7.

Reversibility of alexithymia with effective treatment of moderate-to-severe psoriasis: longitudinal data from EPIDEPSO.

Sampogna F, Puig L, Spuls P, Girolomoni G, Radtke MA, Kirby B, Brunori M, Bergmans P, Smirnov P, Rundle J, Castiglia A, Lavie F, Paul C.

Br J Dermatol. 2019 Feb;180(2):397-403. doi: 10.1111/bjd.17259. Epub 2018 Nov 26.

PMID:
30269346
8.

Personalized prescription of tyrosine kinase inhibitors in unresectable metastatic cholangiocarcinoma.

Poddubskaya EV, Baranova MP, Allina DO, Smirnov PY, Albert EA, Kirilchev AP, Aleshin AA, Sekacheva MI, Suntsova MV.

Exp Hematol Oncol. 2018 Sep 6;7:21. doi: 10.1186/s40164-018-0113-x. eCollection 2018.

9.

PharmacoDB: an integrative database for mining in vitro anticancer drug screening studies.

Smirnov P, Kofia V, Maru A, Freeman M, Ho C, El-Hachem N, Adam GA, Ba-Alawi W, Safikhani Z, Haibe-Kains B.

Nucleic Acids Res. 2018 Jan 4;46(D1):D994-D1002. doi: 10.1093/nar/gkx911.

10.

Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.

Thu KL, Silvester J, Elliott MJ, Ba-Alawi W, Duncan MH, Elia AC, Mer AS, Smirnov P, Safikhani Z, Haibe-Kains B, Mak TW, Cescon DW.

Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):E1570-E1577. doi: 10.1073/pnas.1719577115. Epub 2018 Jan 29.

11.

Author Correction: Gene isoforms as expression-based biomarkers predictive of drug response in vitro.

Safikhani Z, Smirnov P, Thu KL, Silvester J, El-Hachem N, Quevedo R, Lupien M, Mak TW, Cescon D, Haibe-Kains B.

Nat Commun. 2018 Jan 9;9(1):166. doi: 10.1038/s41467-017-02136-5.

12.

Gene isoforms as expression-based biomarkers predictive of drug response in vitro.

Safikhani Z, Smirnov P, Thu KL, Silvester J, El-Hachem N, Quevedo R, Lupien M, Mak TW, Cescon D, Haibe-Kains B.

Nat Commun. 2017 Oct 24;8(1):1126. doi: 10.1038/s41467-017-01153-8. Erratum in: Nat Commun. 2018 Jan 9;9(1):166.

13.

Tissue specificity of in vitro drug sensitivity.

Yao F, Madani Tonekaboni SA, Safikhani Z, Smirnov P, El-Hachem N, Freeman M, Manem VSK, Haibe-Kains B.

J Am Med Inform Assoc. 2018 Feb 1;25(2):158-166. doi: 10.1093/jamia/ocx062.

14.

[Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].

Kustov AV, Strelnikov AI, Moryganov MA, Airapetyan AO, Smirnov PR, Lyalyakina EV, Toms SR.

Urologiia. 2017 Sep;(4):22-26. Russian.

PMID:
28952687
15.

Revisiting inconsistency in large pharmacogenomic studies.

Safikhani Z, Smirnov P, Freeman M, El-Hachem N, She A, Rene Q, Goldenberg A, Birkbak NJ, Hatzis C, Shi L, Beck AH, Aerts HJWL, Quackenbush J, Haibe-Kains B.

Version 3. F1000Res. 2016 Sep 16 [revised 2017 Jan 1];5:2333. doi: 10.12688/f1000research.9611.3. eCollection 2016.

16.

Mathematical Justification of Expression-Based Pathway Activation Scoring (PAS).

Aliper AM, Korzinkin MB, Kuzmina NB, Zenin AA, Venkova LS, Smirnov PY, Zhavoronkov AA, Buzdin AA, Borisov NM.

Methods Mol Biol. 2017;1613:31-51. doi: 10.1007/978-1-4939-7027-8_3.

PMID:
28849557
17.

Design of a HIFU array for the treatment of deep venous thrombosis: a simulation study.

Smirnov P, Hynynen K.

Phys Med Biol. 2017 Jul 12;62(15):6108-6125. doi: 10.1088/1361-6560/aa71fb.

PMID:
28486218
18.

Integrative Cancer Pharmacogenomics to Infer Large-Scale Drug Taxonomy.

El-Hachem N, Gendoo DMA, Ghoraie LS, Safikhani Z, Smirnov P, Chung C, Deng K, Fang A, Birkwood E, Ho C, Isserlin R, Bader GD, Goldenberg A, Haibe-Kains B.

Cancer Res. 2017 Jun 1;77(11):3057-3069. doi: 10.1158/0008-5472.CAN-17-0096. Epub 2017 Mar 17.

19.

[Quantitative mineralogical analysis and structure of urinary stones in patients living in Ivanovo region].

Kustov AV, Strelnikov AI, Smirnov PR, Gusakova SV, Moryganov MA, Toms SR, Gruzdev SI, Airapetyan AO.

Urologiia. 2016 Aug;(3):19-25. Russian.

PMID:
28247625
20.

Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study.

Sampogna F, Puig L, Spuls P, Girolomoni G, Radtke MA, Kirby B, Brunori M, Bergmans P, Smirnov P, Rundle J, Lavie F, Paul C; EPIDEPSO Investigators.

Br J Dermatol. 2017 May;176(5):1195-1203. doi: 10.1111/bjd.15243. Epub 2017 Apr 10.

PMID:
27995617
21.

Safikhani et al. reply.

Safikhani Z, El-Hachem N, Smirnov P, Freeman M, Goldenberg A, Birkbak NJ, Beck AH, Aerts HJ, Quackenbush J, Haibe-Kains B.

Nature. 2016 Nov 30;540(7631):E2-E4. doi: 10.1038/nature19839. No abstract available.

PMID:
27905430
22.

Safikhani et al. reply.

Safikhani Z, El-Hachem N, Smirnov P, Freeman M, Goldenberg A, Birkbak NJ, Beck AH, Aerts HJ, Quackenbush J, Haibe-Kains B.

Nature. 2016 Nov 30;540(7631):E11-E12. doi: 10.1038/nature20581. No abstract available.

PMID:
27905423
23.

Safikhani et al. reply.

Safikhani Z, El-Hachem N, Smirnov P, Freeman M, Goldenberg A, Birkbak NJ, Beck AH, Aerts HJ, Quackenbush J, Haibe-Kains B.

Nature. 2016 Nov 30;540(7631):E6-E8. doi: 10.1038/nature20172. No abstract available.

PMID:
27905416
24.

Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis.

Augustin M, Blome C, Paul C, Puig L, Luger T, Lambert J, Chimenti S, Girolomoni G, Kragballe K, Naessens D, Bergmans P, Smirnov P, Barker J, Reich K.

J Eur Acad Dermatol Venereol. 2017 Feb;31(2):294-303. doi: 10.1111/jdv.13823. Epub 2016 Aug 12.

PMID:
27515070
25.

Assessment of pharmacogenomic agreement.

Safikhani Z, El-Hachem N, Quevedo R, Smirnov P, Goldenberg A, Juul Birkbak N, Mason C, Hatzis C, Shi L, Aerts HJ, Quackenbush J, Haibe-Kains B.

F1000Res. 2016 May 9;5:825. doi: 10.12688/f1000research.8705.1. eCollection 2016.

26.

PharmacoGx: an R package for analysis of large pharmacogenomic datasets.

Smirnov P, Safikhani Z, El-Hachem N, Wang D, She A, Olsen C, Freeman M, Selby H, Gendoo DM, Grossmann P, Beck AH, Aerts HJ, Lupien M, Goldenberg A, Haibe-Kains B.

Bioinformatics. 2016 Apr 15;32(8):1244-6. doi: 10.1093/bioinformatics/btv723. Epub 2015 Dec 9.

PMID:
26656004
27.

Personalized diagnosis of medulloblastoma subtypes across patients and model systems.

Gendoo DM, Smirnov P, Lupien M, Haibe-Kains B.

Genomics. 2015 Aug;106(2):96-106. doi: 10.1016/j.ygeno.2015.05.002. Epub 2015 May 12.

28.

Signaling pathways activation profiles make better markers of cancer than expression of individual genes.

Borisov NM, Terekhanova NV, Aliper AM, Venkova LS, Smirnov PY, Roumiantsev S, Korzinkin MB, Zhavoronkov AA, Buzdin AA.

Oncotarget. 2014 Oct 30;5(20):10198-205.

29.

Exceptionally mild palladium(II)-catalyzed dehydrogenative C-H/C-H arylation of indolines at the C-7 position under air.

Jiao LY, Smirnov P, Oestreich M.

Org Lett. 2014 Nov 21;16(22):6020-3. doi: 10.1021/ol503035z. Epub 2014 Nov 6.

PMID:
25375317
30.

Formation of three new bonds and two stereocenters in acyclic systems by zinc-mediated enantioselective alkynylation of acylsilanes, Brook rearrangement, and ene-allene carbocyclization reactions.

Smirnov P, Katan E, Mathew J, Kostenko A, Karni M, Nijs A, Bolm C, Apeloig Y, Marek I.

J Org Chem. 2014 Dec 19;79(24):12122-35. doi: 10.1021/jo501977r. Epub 2014 Oct 22.

PMID:
25271364
31.

Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data.

Buzdin AA, Zhavoronkov AA, Korzinkin MB, Venkova LS, Zenin AA, Smirnov PY, Borisov NM.

Front Genet. 2014 Mar 25;5:55. doi: 10.3389/fgene.2014.00055. eCollection 2014.

32.

The OncoFinder algorithm for minimizing the errors introduced by the high-throughput methods of transcriptome analysis.

Buzdin AA, Zhavoronkov AA, Korzinkin MB, Roumiantsev SA, Aliper AM, Venkova LS, Smirnov PY, Borisov NM.

Front Mol Biosci. 2014 Aug 26;1:8. doi: 10.3389/fmolb.2014.00008. eCollection 2014.

33.

One-pot zinc-promoted asymmetric alkynylation/brook-type rearrangement/ene-allene cyclization: highly selective formation of three new bonds and two stereocenters in acyclic systems.

Smirnov P, Mathew J, Nijs A, Katan E, Karni M, Bolm C, Apeloig Y, Marek I.

Angew Chem Int Ed Engl. 2013 Dec 16;52(51):13717-21. doi: 10.1002/anie.201306749. Epub 2013 Oct 23.

PMID:
24155160
34.

Observations on the viability of C6-glioma cells after sonoporation with low-intensity ultrasound and microbubbles.

Van Ruijssevelt L, Smirnov P, Yudina A, Bouchaud V, Voisin P, Moonen C.

IEEE Trans Ultrason Ferroelectr Freq Control. 2013 Jan;60(1):34-45. doi: 10.1109/TUFFC.2013.2535.

PMID:
23287911
35.

MRI contrast variation of thermosensitive magnetoliposomes triggered by focused ultrasound: a tool for image-guided local drug delivery.

Lorenzato C, Cernicanu A, Meyre ME, Germain M, Pottier A, Levy L, de Senneville BD, Bos C, Moonen C, Smirnov P.

Contrast Media Mol Imaging. 2013 Mar-Apr;8(2):185-92. doi: 10.1002/cmmi.1515.

PMID:
23281291
36.

Chemolysis of calcium oxalate stones: study in vitro and possible clinical application.

Kustov AV, Shevyrin AA, Strel'nikov AI, Smirnov PR, Trostin VN.

Urol Res. 2012 Jun;40(3):205-9. doi: 10.1007/s00240-011-0429-z. Epub 2011 Nov 17.

PMID:
22089056
37.

Ultrasound-mediated intracellular drug delivery using microbubbles and temperature-sensitive liposomes.

Yudina A, de Smet M, Lepetit-Coiffé M, Langereis S, Van Ruijssevelt L, Smirnov P, Bouchaud V, Voisin P, Grüll H, Moonen CT.

J Control Release. 2011 Nov 7;155(3):442-8. doi: 10.1016/j.jconrel.2011.06.006. Epub 2011 Jun 12.

PMID:
21689699
39.

In vivo single cell detection of tumor-infiltrating lymphocytes with a clinical 1.5 Tesla MRI system.

Smirnov P, Poirier-Quinot M, Wilhelm C, Lavergne E, Ginefri JC, Combadière B, Clément O, Darrasse L, Gazeau F.

Magn Reson Med. 2008 Dec;60(6):1292-7. doi: 10.1002/mrm.21812.

40.

In vivo imaging of transplanted hepatocytes with a 1.5-T clinical MRI system--initial experience in mice.

Luciani A, Parouchev A, Smirnov P, Braga G, Wilhelm C, Gazeau F, Boudechiche L, L'hermine-Coulomb A, Dagher I, Franco D, Rahmouni A, Hadchouel M, Weber A, Clement O.

Eur Radiol. 2008 Jan;18(1):59-69. Epub 2007 Oct 5.

41.

Magnetic control of vascular network formation with magnetically labeled endothelial progenitor cells.

Wilhelm C, Bal L, Smirnov P, Galy-Fauroux I, Clément O, Gazeau F, Emmerich J.

Biomaterials. 2007 Sep;28(26):3797-806. Epub 2007 May 10.

PMID:
17544118
42.

Single-cell detection by gradient echo 9.4 T MRI: a parametric study.

Smirnov P, Gazeau F, Beloeil JC, Doan BT, Wilhelm C, Gillet B.

Contrast Media Mol Imaging. 2006 Jul-Aug;1(4):165-74.

PMID:
17193693
43.

In vivo cellular imaging of lymphocyte trafficking by MRI: a tumor model approach to cell-based anticancer therapy.

Smirnov P, Lavergne E, Gazeau F, Lewin M, Boissonnas A, Doan BT, Gillet B, Combadière C, Combadière B, Clément O.

Magn Reson Med. 2006 Sep;56(3):498-508.

44.

Phenotypic study of human gingival fibroblasts labeled with superparamagnetic anionic nanoparticles.

Naveau A, Smirnov P, Ménager C, Gazeau F, Clément O, Lafont A, Gogly B.

J Periodontol. 2006 Feb;77(2):238-47.

PMID:
16460250
45.

In vivo cellular imaging of magnetically labeled hybridomas in the spleen with a 1.5-T clinical MRI system.

Smirnov P, Gazeau F, Lewin M, Bacri JC, Siauve N, Vayssettes C, Cuénod CA, Clément O.

Magn Reson Med. 2004 Jul;52(1):73-9.

46.

Spatial and temporal control of transgene expression in vivo using a heat-sensitive promoter and MRI-guided focused ultrasound.

Guilhon E, Voisin P, de Zwart JA, Quesson B, Salomir R, Maurange C, Bouchaud V, Smirnov P, de Verneuil H, Vekris A, Canioni P, Moonen CT.

J Gene Med. 2003 Apr;5(4):333-42.

PMID:
12692867
47.

[The metabolism and biological activity of glucuronidation substrates in experimental diabetes mellitus].

Krylov IuF, Smirnov PA, Flerovskiĭ AA.

Eksp Klin Farmakol. 1992 Nov-Dec;55(6):35-7. Russian.

PMID:
1305873
48.

[The biological activity of chalone-like proteoglycans isolated from the spleen and thymus at various periods of ontogeny].

Ronichevskaia GM, Smirnov PN, Goncharova NB, Zlobina GA.

Ontogenez. 1989 Jul-Aug;20(4):409-15. Russian.

PMID:
2529463
49.

[Change in carbohydrate metabolism, secretion of insulin and glucagon in normoglycemic rats during administration of various doses of nicotinamide].

Krylov IuF, Kononenkko TL, Smirnov PA, Tigranian RA, Kalita NF.

Vopr Med Khim. 1989 May-Jun;35(3):30-2. Russian.

PMID:
2528238
50.

[The activity of growth-regulating substances isolated from the spleen and thymus of healthy cows and of those with hemoblastoses].

Ronichevskaia GM, Zlobina GA, Smirnova VV, Smirnov PN.

Eksp Onkol. 1989;11(4):63-6. Russian.

PMID:
2547575

Supplemental Content

Loading ...
Support Center